Clinical Trial Update: Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 study of novel regimens for relapsed or refractory multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: iTeos Therapeutics | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED